An Assessment of the Knowledge and Perceptions of Precision Medicine (PM) in the Rwandan Healthcare Setting
Authors:
- Clarisse MusanabaganwaCMClarisse Musanabaganwa
- Hinda RutonHRHinda Ruton
- Deogratias RuhangazaDRDeogratias Ruhangaza
- Nicaise NsabimanaNNNicaise Nsabimana
- Emmanuel KayitareEKEmmanuel Kayitare
- Thierry Zawadi MuvunyiTMThierry Zawadi Muvunyi
- Muhammed SemakulaMSMuhammed Semakula
- Faustin NtirenganyaFNFaustin Ntirenganya
- Emile MusoniEMEmile Musoni
- Jules NdoliJNJules Ndoli
- Elisee HategekimanaEHElisee Hategekimana
- Angus NassirANAngus Nassir
Open Access
- 14 December 2023
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (12) , 1707
Abstract
Introduction: Precision medicine (PM) or personalized medicine is an innovative approach that aims to tailor disease prevention and treatment to consider the differences in people’s genes, environments, and lifestyles. Although many efforts have been made to accelerate the universal adoption of PM, several challenges need to be addressed in order to advance PM in Africa. Therefore, our study aimed to establish baseline data on the knowledge and perceptions of the implementation of PM in the Rwandan healthcare setting. Method: A descriptive qualitative study was conducted in five hospitals offering diagnostics and oncology services to cancer patients in Rwanda. To understand the existing policies regarding PM implementation in the country, two additional institutions were surveyed: the Ministry of Health (MOH), which creates and sets policies for the overall vision of the health sector, and the Rwanda Biomedical Center (RBC), which coordinates the implementation of health sector policies in the country. The researchers conducted 32 key informant interviews and assessed the functionality of available PM equipment in the 5 selected health facilities. The data were thematically categorized and analyzed. Results: The study revealed that PM is perceived as a complex and expensive program by most health managers and health providers. The most cited challenges to implementing PM included the following: the lack of policies and guidelines; the lack of supportive infrastructures and limited suppliers of required equipment and laboratory consumables; financial constraints; cultural, behavioral, and religious beliefs; and limited trained, motivated, and specialized healthcare providers. Regarding access to health services for cancer treatment, patients with health insurance pay 10% of their medical costs, which is still too expensive for Rwandans. Conclusion: The study participants highlighted the importance of PM to enhance healthcare delivery if the identified barriers are addressed. For instance, Rwandan health sector leadership might consider the creation of specialized oncology centers in all or some referral hospitals with all the necessary genomic equipment and trained staff to serve the needs of the country and implement a PM program.Keywords
Funding Information
- National Council for Science and Technology (NCST-NRIF/ERG-BATCH1/P01/2019)
This publication has 37 references indexed in Scilit:
- Cancer Precision Medicine: From Cancer Screening to Drug Selection and Personalized ImmunotherapyTrends in Pharmacological Sciences, 2017
- Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in GermanyAdvances in Therapy, 2016
- Precision Medicine and Low- to Middle-Income CountriesJAMA Oncology, 2016
- Seven Questions for Personalized MedicineJAMA, 2015
- Ten things we have to do to achieve precision medicineScience, 2015
- Translational Genomics in Low- and Middle-Income Countries: Opportunities and ChallengesPublic Health Genomics, 2015
- Enabling the genomic revolution in AfricaScience, 2014
- Breast cancer survivors willingness to participate in an acupuncture clinical trial: a qualitative studySupportive Care in Cancer, 2013
- Disparities in Breast Cancer Treatment and Outcomes: Biological, Social, and Health System Determinants and Opportunities for ResearchThe Oncologist, 2013
- Pharmacogenetics/genomics and personalized medicineHuman Molecular Genetics, 2005